Arena Pharmaceuticals, Inc. Contract with Customer, Asset, after Allowance for Credit Loss
Arena Pharmaceuticals, Inc. had Contract with Customer, Asset, after Allowance for Credit Loss of $4.10 million as of 2018-01-01, per its 10-K filed 2019-02-28.
Discontinued › Balance Sheet › Assets
us-gaap:ContractWithCustomerAssetNet · last filed 2019-02-28
- 2018-01-01: Contract with Customer, Asset, after Allowance for Credit Loss $4.10M.
- 2017-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $4.10M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss |
|---|---|
| 2018-01-01 | $4.10M 10-K · filed 2019-02-28 |
| 2017-12-31 | $4.10M 10-Q · filed 2018-11-08 |